Lisinopril
- Product NDC
- 51655-273
- 11-digit product format
- 516550273
- Labeler code
- 51655
- Product ID
- 51655-273_d4790a90-4368-bd13-e053-2a95a90a4eb5
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lisinopril
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Northwind Pharmaceuticals
- Application
- ANDA076059
- Marketing category
- ANDA
- Marketing start
- 2020-05-01
- Marketing end
- 0000-00-00
- Substance
- LISINOPRIL
- Active strength
- 10 mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51655-273 | LISINOPRIL TABLET [NORTHWIND PHARMACEUTICALS] | 2 | Legacy NDC | 20220101_addc7591-6303-afca-e053-2a95a90adf74.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51655-273-26 | 51655027326 | 90 TABLET in 1 BOTTLE, PLASTIC (51655-273-26) | 90 tablet | 2020-05-01 | 0000-00-00 | No | No | Current |